Nominated by: Spanish Bioindustry Association – AseBio, Lithianian Biotechnology Association People in nomination: Professor Francisco Martinez Mojica, Department of Physiology, Genetics and Microbiology, University of..Read More
Nominated by: PTC Therapeutics Organisation in nomination: PTC Therapeutics Diseases associated with protein disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy have long been..Read More
Nominated by: Pfizer Organisations in nomination: Pfizer The Pfizer Grange Castle Biotechnology facility commenced construction in 2000 and was licensed and officially opened in 2005. It..Read More
Nominated by: Spanish Bioindustry Association – AseBio Organisation in nomination: Pharmamar (Spain) Marine environments are considered more biologically diverse than..Read More
Nominated by: Kite (a Gilead Company) Organisations in nomination: Kite (a Gilead Company) Non-Hodgkin lymphoma (NHL) can occur at any age, and accounts for an..Read More
Nominated by: Sobi, Swedish Orphan Biovitrum Organisations in nomination: DevelopAKUre Consortium AKU is a serious, multi-system disorder affecting approximately 1 in 250,000 people, first described as..Read More
Nominated by: Swiss Biotech Association Organisations in nomination: Glycart Biotechnology (now Roche Glycart AG) Pioneer in antibody glycosylation (glycoMAb) technology increasing immune-mediated killing of cancer cells..Read More
Nominated by: Scienceindustries Switzerland Organisation in nomination: Swiss Federal Institute of Technology, University of Freiburg In 2000, the research teams of Ingo Potrykus (Swiss Federal..Read More
Nominated by: UK BioIndustry Association Organisation in nomination: DeepMind An artificial intelligence (AI) network developed by Google AI offshoot DeepMind made a gargantuan leap in solving..Read More
Nominated by: Novartis Organisations in nomination: Novartis Acute lymphoblastic leukaemia (ALL) is a type of cancer that affects white blood cells. It progresses quickly and aggressively..Read More
Nominated by: Voisin Consulting Life Sciences The European “1+ Million Genomes” Initiative builds from the achievements of the Human Genome Project and aims to have at..Read More
Nominated by: Pfizer Organisations in nomination: Pfizer, BioNTech In March 2020, the WHO declared COVID-19 a pandemic. At “lightspeed,” Pfizer collaborated with BioNTech, a..Read More
Nominated by: Federchimica Assobiotec Organisation in nomination: Novamont (Italy) 1,4, Butanediol is a chemical intermediate used for a wide range of applications, including industrial processes (as..Read More